Immune checkpoint inhibitor-associated acute kidney injury and mortality: An observational study.
<h4>Background</h4>Immune checkpoint inhibitors, approved for the treatment of various types of cancer, are known to cause a unique spectrum of side effects, including acute kidney injury (AKI). The aim of this study was to describe the incidence, risk factors, renal outcomes, and mortal...
Guardado en:
Autores principales: | Marije S Koks, Gurbey Ocak, Britt B M Suelmann, Cornelia A R Hulsbergen-Veelken, Saskia Haitjema, Marieke E Vianen, Marianne C Verhaar, Karin A H Kaasjager, Meriem Khairoun |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/144c8c5576d040aa8607d7a60a1e893b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Ambiguous definitions for baseline serum creatinine affect acute kidney diagnosis at the emergency department
por: Michael Niemantsverdriet, et al.
Publicado: (2021) -
Acute kidney injury in patients treated with immune checkpoint inhibitors
por: Enriqueta Felip, et al.
Publicado: (2021) -
Checkpoints
por: Jean Arasanayagam
Publicado: (2016) -
Course of symptoms and health-related quality of life during specialized pre-dialysis care.
por: Moniek C M de Goeij, et al.
Publicado: (2014) -
Effect of ondansetron on reducing ICU mortality in patients with acute kidney injury
por: Xiaojiang Guo, et al.
Publicado: (2021)